These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1290997)

  • 1. National Advisory Committee on Immunization (NACI). Revised guidelines for booster vaccination against hepatitis B.
    Can Commun Dis Rep; 1992 Aug; 18(16):121-2. PubMed ID: 1290997
    [No Abstract]   [Full Text] [Related]  

  • 2. Statement on alternate adolescent schedule for hepatitis B vaccine (ACS-5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI).
    Can Commun Dis Rep; 2000 Jul; 26():19-20. PubMed ID: 10927839
    [No Abstract]   [Full Text] [Related]  

  • 3. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on hepatitis prevention.
    Can Commun Dis Rep; 1997 Sep; 23():1-6. PubMed ID: 9327646
    [No Abstract]   [Full Text] [Related]  

  • 4. [Revised guidelines related to booster vaccines against hepatitis B. The National Conference Committee on Immunization].
    Union Med Can; 1993; 122(1):47. PubMed ID: 8465476
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current status of hepatitis B immunization and strengthened immune memory among first-year middle school students in Tianjin].
    Shan AL; Li C; Wu WS; He HY; Liu Y; Liu P; Xie XH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2010 Jun; 44(6):531-4. PubMed ID: 21055129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National advisory committee on immunization (NACI). Statement on hepatitis B vaccine.
    Can Commun Dis Rep; 1993 Jul; 19(14):104-15. PubMed ID: 8364441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B vaccination: time for a booster?
    Shopper T
    LDA J; 1992; 51(3):5-6. PubMed ID: 9518764
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B and the need for a booster dose.
    Leuridan E; Van Damme P
    Clin Infect Dis; 2011 Jul; 53(1):68-75. PubMed ID: 21653306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents.
    Gabbuti A; Romanò L; Blanc P; Meacci F; Amendola A; Mele A; Mazzotta F; Zanetti AR
    Vaccine; 2007 Apr; 25(16):3129-32. PubMed ID: 17291637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.
    Fitzsimons D; François G; Hall A; McMahon B; Meheus A; Zanetti A; Duval B; Jilg W; Böcher WO; Lu SN; Akarca U; Lavanchy D; Goldstein S; Banatvala J; Damme PV
    Vaccine; 2005 Jul; 23(32):4158-66. PubMed ID: 15964484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revised guidelines for booster vaccination against hepatitis B.
    Holton D
    CMAJ; 1992 Oct; 147(7):1029-32. PubMed ID: 1393899
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years.
    Hammitt LL; Hennessy TW; Fiore AE; Zanis C; Hummel KB; Dunaway E; Bulkow L; McMahon BJ
    Vaccine; 2007 Sep; 25(39-40):6958-64. PubMed ID: 17714836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study.
    Bialek SR; Bower WA; Novak R; Helgenberger L; Auerbach SB; Williams IT; Bell BP
    Pediatr Infect Dis J; 2008 Oct; 27(10):881-5. PubMed ID: 18756185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-two years follow-up of a prospective randomized trial of hepatitis B vaccines without booster dose in children: final report.
    But DY; Lai CL; Lim WL; Fung J; Wong DK; Yuen MF
    Vaccine; 2008 Dec; 26(51):6587-91. PubMed ID: 18835318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules.
    Wilson JN; Nokes DJ; Medley GF; Shouval D
    Vaccine; 2007 May; 25(18):3705-12. PubMed ID: 17306427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody kinetics among 8-10 years old respondents to hepatitis B vaccination in a low endemic country and the effect of a booster dose given 5 or 10 years later.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Massé R; Duval B
    Vaccine; 2009 Oct; 27(43):6048-53. PubMed ID: 19683086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statement on hepatitis B vaccine. National Advisory Committee on Immunization.
    CMAJ; 1993 Nov; 149(10):1465-80. PubMed ID: 8221430
    [No Abstract]   [Full Text] [Related]  

  • 19. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
    Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Why are boosters no longer necessary for protection against hepatitis B?].
    Siegrist CA
    Rev Prat; 2004 Mar; 54(5):509-11. PubMed ID: 15176509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.